Noteworthy, enhanced mitochondrial fission in PDAC could be reversed by overexpression of Mfn2 or by its pharmacologic reactivation with leflunomide, an oral FDA-approved anti-arthritis drug which could be likely repurposed as chemotherapeutic agent in this cancer [48]. Here, MFN2 is linked to cancer.